KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) EBITDA Margin (2016 - 2025)

Teladoc Health (TDOC) has disclosed EBITDA Margin for 12 consecutive years, with 3.93% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 382.0% to 3.93% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.77% through Dec 2025, up 3125.0% year-over-year, with the annual reading at 7.77% for FY2025, 3125.0% up from the prior year.
  • EBITDA Margin hit 3.93% in Q4 2025 for Teladoc Health, up from 7.78% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 2.91% in Q4 2021 to a low of 1181.51% in Q1 2022.
  • Historically, EBITDA Margin has averaged 131.7% across 5 years, with a median of 11.82% in 2023.
  • Biggest five-year swings in EBITDA Margin: plummeted -113453bps in 2022 and later soared 117079bps in 2023.
  • Year by year, EBITDA Margin stood at 2.91% in 2021, then crashed by -20384bps to 596.44% in 2022, then soared by 99bps to 3.69% in 2023, then tumbled by -110bps to 7.76% in 2024, then skyrocketed by 49bps to 3.93% in 2025.
  • Business Quant data shows EBITDA Margin for TDOC at 3.93% in Q4 2025, 7.78% in Q3 2025, and 4.88% in Q2 2025.